NASDAQ:EVFM

Evofem Biosciences Stock News

etoro logo Buy EVFM
*Your capital is at risk
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
In this article you are going to find out whether hedge funds think Evofem Biosciences, Inc. (NASDAQ:EVFM) is a good investment right now. We like to check what the smart money thinks first before doi

AS setujui alat KB terbaru, pakai gel

05:45am, Saturday, 30'th May 2020
Pemerintah Amerika Serikat minggu lalu menyetujui alat kontrasepsi terbaru berbentuk gel yang bisa mencegah kehamilan, Phexxi. Caranya, Phexxi dipakai ...
A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the
Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Ballard Power Systems Inc, Allegheny Technologies Incorporated, Apache Corporation. Read Harry Boxer's latest article on Investing.com

Finally, Some Good News for Evofem Biosciences

10:30am, Thursday, 28'th May 2020
Here's why a company making a novel contraceptive will be well awarded for tackling an old problem with a new twist.

Company News for May 27, 2020

02:56pm, Wednesday, 27'th May 2020
Companies In The News Are: EVFM, BNFT, SRNE, CLRB
Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ballard Power Systems Inc, MGM Resorts International, Darden Restaurants Inc. Read Harry Boxer's latest article on Investing.com
In the current session, Evofem Biosciences Inc. (NASDAQ: EVFM) is trading at $6.04, after a 21% increase. Over the past month, the stock increased by 25.57%, and in the past year, by 2.03%. With perfo
Evofem Biosciences was rising sharply Tuesday after the Food and Drug Administration approved Phexxi, the company's birth-control gel. Phexxi is a non-hormonal, vaginal pH regulator contraceptive de

Why Evofem Biosciences Stock Is on Fire Today

01:00pm, Tuesday, 26'th May 2020
Shares of the small-cap biotech Evofem Biosciences (NASDAQ: EVFM) rose by as much as 42.5% in pre-market trading Tuesday morning. The company's stock is taking flight in response to the Food and Dru
On Friday, the FDA approved Evofem Biosciences Inc.'s Phexxi contraceptive gel. The stock is up sharply Tuesday morning so let's check out a few charts to give us some reference points. In the dail
Takeda's brigatinib is approved for a type of non-small cell lung cancer, or NSCLC. Zealand Pharma's NDA for Hypopal rescue pen is accepted. EvoFem's contracept
Basketball: Bogut puts playing future on hold in uncertain times

Wall Street Breakfast: The Week Ahead

11:16am, Sunday, 24'th May 2020
Welcome to Wall Street Brunch, our preview of stock market events for investors to watch during the upcoming week. You can also catch this article a day early b
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE